# Regeneron Pharmaceuticals, Inc. (REGN) — Q1-2009 Earnings Results

**Report date:** 2009-04-30 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q1-2009

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Misses on EPS, Stock Down 1.63%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.22 | N/A | +24.14% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed caution regarding market conditions and highlighted the importance of strategic investments. They remain focused on future opportunities.

**Key quotes:**

> Management noted challenges in the current market environment.

> They emphasized a focus on long-term growth despite short-term setbacks.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Regeneron's earnings report showed a loss per share that exceeded expectations, which may indicate ongoing challenges for the company. The stock reacted negatively, declining by 1.63%, likely due to concerns over market conditions and the lack of revenue data. Investors will be watching closely for future updates on performance and strategy.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q1-2009_